Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 20-Feb-24 9:23 AM View:  | Accenture Plc (ACN) | 15-Feb-24 | Grant | 4 | -- | -- | < 1% 6.84K to 6.84K | |
| 20-Feb-24 9:23 AM View: | Accenture Plc (ACN) | 15-Feb-24 | Payment of Exercise | 2 | $372.35 | $744.70 | (< 1%) 6.84K to 6.84K | |
| 05-Feb-24 9:19 AM View: | Accenture Plc (ACN) | 01-Feb-24 | Payment of Exercise | 549 | $367.33 | $201,665.00 | (7%) 7.39K to 6.84K | (2%) |
| 01-Feb-24 5:02 PM View: | Accenture Plc (ACN) | 31-Jan-24 | Grant | 859 | -- | -- | 13% 6.53K to 7.39K | |
| 16-Nov-23 7:15 PM View: | Accenture Plc (ACN) | 15-Nov-23 | Grant | 5 | -- | -- | < 1% 6.53K to 6.53K | |
| 16-Aug-23 4:26 PM View: | Accenture Plc (ACN) | 15-Aug-23 | Grant | 5 | -- | -- | < 1% 6.52K to 6.53K | |
| 16-May-23 4:17 PM View: | Accenture Plc (ACN) | 15-May-23 | Grant | 5 | -- | -- | < 1% 6.52K to 6.52K | |
| 17-Feb-23 9:18 AM View: | Accenture Plc (ACN) | 15-Feb-23 | Grant | 4 | -- | -- | < 1% 6.51K to 6.52K | |
| 17-Feb-23 9:18 AM View: | Accenture Plc (ACN) | 15-Feb-23 | Payment of Exercise | 2 | $284.90 | $569.80 | (< 1%) 6.52K to 6.52K | |
| 02-Feb-23 4:52 PM View: | Accenture Plc (ACN) | 01-Feb-23 | Grant | 1,127 | -- | -- | 21% 5.39K to 6.51K | |
| 30-Jan-23 4:16 PM View: | Accenture Plc (ACN) | 26-Jan-23 | Payment of Exercise | 400 | $274.10 | $109,639.00 | (7%) 5.79K to 5.39K | |
| 17-Nov-22 5:49 PM View: | Accenture Plc (ACN) | 15-Nov-22 | Grant | 4 | -- | -- | < 1% 5.78K to 5.79K | |
| 17-Aug-22 4:34 PM View: | Accenture Plc (ACN) | 15-Aug-22 | Grant | 3 | -- | -- | < 1% 5.78K to 5.78K | |
| 17-May-22 8:59 AM View: | Accenture Plc (ACN) | 13-May-22 | Grant | 4 | -- | -- | < 1% 5.78K to 5.78K | |
| 03-May-22 6:09 PM View: | Abbott Laboratories (ABT) | 29-Apr-22 | Grant | 1,602 | -- | -- | 5% 31.8K to 33.41K | |
| 25-Feb-22 5:23 PM View: | Abbott Laboratories (ABT) | 24-Feb-22 | Option Exercise | 6,280 | $29.84 | $187,394.00 | 23% 27.14K to 33.42K | |
| 25-Feb-22 5:23 PM View: | Abbott Laboratories (ABT) | 24-Feb-22 | Option Sale | 1,614 | $116.43 | $187,910.00 | (5%) 33.42K to 31.8K | |
| 17-Feb-22 5:04 PM View: | Accenture Plc (ACN) | 15-Feb-22 | Grant | 4 | -- | -- | < 1% 5.77K to 5.78K | |
| 17-Feb-22 5:04 PM View: | Accenture Plc (ACN) | 15-Feb-22 | Payment of Exercise | 2 | $330.34 | $660.68 | (< 1%) 5.78K to 5.78K | |
| 04-Feb-22 5:02 PM View: | Accenture Plc (ACN) | 03-Feb-22 | Payment of Exercise | 566 | $347.95 | $196,941.00 | (9%) 6.34K to 5.77K | (7%) |
| 27-Jan-22 5:18 PM View: | Accenture Plc (ACN) | 26-Jan-22 | Grant | 911 | -- | -- | 17% 5.43K to 6.34K | |
| 16-Nov-21 5:09 PM View: | Accenture Plc (ACN) | 15-Nov-21 | Grant | 4 | -- | -- | < 1% 5.42K to 5.43K | |
| 17-Aug-21 8:55 AM View: | Accenture Plc (ACN) | 13-Aug-21 | Grant | 4 | -- | -- | < 1% 5.42K to 5.42K | |
| 17-May-21 5:28 PM View: | Accenture Plc (ACN) | 14-May-21 | Grant | 4 | -- | -- | < 1% 5.42K to 5.42K | |
| 27-Apr-21 7:08 PM View: | Abbott Laboratories (ABT) | 23-Apr-21 | Grant | 1,499 | -- | -- | 6% 25.64K to 27.14K | |
| 16-Feb-21 9:02 AM View: | Accenture Plc (ACN) | 12-Feb-21 | Grant | 4 | -- | -- | < 1% 5.42K to 5.42K | |
| 16-Feb-21 9:02 AM View: | Accenture Plc (ACN) | 12-Feb-21 | Payment of Exercise | 2 | $257.00 | $514.00 | (< 1%) 5.42K to 5.42K | (24%) |
| 04-Feb-21 4:23 PM View: | Accenture Plc (ACN) | 03-Feb-21 | Grant | 1,167 | -- | -- | 27% 4.25K to 5.42K | |
| 02-Feb-21 4:44 PM View: | Accenture Plc (ACN) | 30-Jan-21 | Payment of Exercise | 517 | $245.48 | $126,913.00 | (11%) 4.76K to 4.25K | (30%) |
| 17-Nov-20 5:04 PM View: | Accenture Plc (ACN) | 13-Nov-20 | Grant | 4 | -- | -- | < 1% 4.76K to 4.76K | |
| 18-Aug-20 8:29 AM View: | Accenture Plc (ACN) | 14-Aug-20 | Grant | 4 | -- | -- | < 1% 4.76K to 4.76K | |
| 19-May-20 9:15 AM View: | Accenture Plc (ACN) | 15-May-20 | Grant | 5 | $180.90 | $904.47 | < 1% 4.75K to 4.76K | 75% |
| 28-Apr-20 5:24 PM View: | Abbott Laboratories (ABT) | 24-Apr-20 | Grant | 1,974 | -- | -- | 8% 23.67K to 25.64K | |
| 19-Feb-20 4:13 PM View: | Accenture Plc (ACN) | 14-Feb-20 | Grant | 7 | -- | -- | < 1% 4.75K to 4.76K | |
| 19-Feb-20 4:13 PM View: | Accenture Plc (ACN) | 14-Feb-20 | Payment of Exercise | 4 | $212.44 | $849.77 | (< 1%) 4.76K to 4.75K | (49%) |
| 04-Feb-20 4:22 PM View: | Accenture Plc (ACN) | 01-Feb-20 | Payment of Exercise | 867 | $206.81 | $179,308.00 | (15%) 5.62K to 4.75K | (53%) |
| 03-Feb-20 5:30 PM View: | Accenture Plc (ACN) | 30-Jan-20 | Grant | 1,062 | -- | -- | 23% 4.55K to 5.62K | |
| 19-Nov-19 4:18 PM View: | Accenture Plc (ACN) | 15-Nov-19 | Grant | 8 | -- | -- | < 1% 4.55K to 4.55K | |
| 17-May-19 9:07 AM View: | Accenture Plc (ACN) | 15-May-19 | Grant | 15 | -- | -- | < 1% 4.53K to 4.55K | |
| 30-Apr-19 5:11 PM View: | Abbott Laboratories (ABT) | 26-Apr-19 | Grant | 2,241 | -- | -- | 10% 21.43K to 23.67K | |
| 11-Feb-19 4:21 PM View: | Accenture Plc (ACN) | 07-Feb-19 | Payment of Exercise | 821 | $155.10 | $127,333.00 | (15%) 5.35K to 4.53K | (104%) |
| 05-Feb-19 4:21 PM View: | Accenture Plc (ACN) | 01-Feb-19 | Grant | 1,780 | -- | -- | 50% 3.57K to 5.35K | |
| 19-Nov-18 4:37 PM View: | Accenture Plc (ACN) | 15-Nov-18 | Grant | 16 | -- | -- | < 1% 3.56K to 3.57K | |
| 17-May-18 5:58 PM View: | Accenture Plc (ACN) | 15-May-18 | Grant | 15 | -- | -- | < 1% 3.54K to 3.56K | |
| 01-May-18 7:10 PM View: | Abbott Laboratories (ABT) | 27-Apr-18 | Grant | 2,945 | -- | -- | 16% 18.48K to 21.43K | |
| 13-Feb-18 4:24 PM View: | Accenture Plc (ACN) | 10-Feb-18 | Payment of Exercise | 766 | $151.89 | $116,348.00 | (18%) 4.31K to 3.54K | (104%) |
| 09-Feb-18 9:26 AM View: | Accenture Plc (ACN) | 07-Feb-18 | Grant | 1,682 | -- | -- | 64% 2.63K to 4.31K | |
| 17-Nov-17 4:22 PM View: | Accenture Plc (ACN) | 15-Nov-17 | Grant | 15 | -- | -- | < 1% 2.61K to 2.63K | |
| 03-Aug-17 4:31 PM View: | Accenture Plc (ACN) | 01-Aug-17 | Payment of Exercise | 935 | $129.42 | $121,008.00 | (26%) 3.54K to 2.61K | (138%) |
| 16-May-17 4:13 PM View: | Accenture Plc (ACN) | 15-May-17 | Grant | 36 | -- | -- | 1% 3.51K to 3.54K |